Colchicine Tablet, Film Coated
FDA Label NDC 60687-727

42 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Colchicine (NDC 60687-727). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 gout flares, 1.2 familial mediterranean fever (fmf), 2 dosage and administration, 2.1 gout flares, 2.2 fmf, 2.3 recommended pediatric dosage, 2.4 dose modification for coadministration of interacting drugs, 2.5 dose modification in renal impairment, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel - Carton - 0.6 Mg 30Ud

NDC 60687- 727-21

Colchicine
Tablets, USP

0.6 mg

30 Tablets (3 x 10)                 Rx Only

PHARMACIST: Dispense with Medication Guide to each patient.

Each Film-Coated Tablet Contains:
Colchicine, USP .......................................................................0.6 mg

Usual Dosage: See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Protect from light.

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 49884-171, Endo USA.

Distributed by: American Health Packaging, Columbus, Ohio 43217

772721
0472721/0725

Package/Label Display Panel – Blister – 0.6 Mg

Colchicine
Tablet, USP

0.6 mg

* Please review the disclaimer below.